并购会催动产业“整合竞速”,但不构成市场担心的“一家独大”,国产ADC CDMO依然在“齐放争鸣”的路上昂扬行进。最高31亿港元“闪电收购”,合联缓解“产能饥渴”东曜“成功上岸”Guide View1月14日,药明合联宣布以每股4港元现金发起自愿要约,拟收购东曜药业,假设要约获全面接纳,最高总代价约为31.047亿港元,若药明合联最后获得东曜药业60%的股权,代价预计为18.55亿港元。收购完成后...
Source Link并购会催动产业“整合竞速”,但不构成市场担心的“一家独大”,国产ADC CDMO依然在“齐放争鸣”的路上昂扬行进。最高31亿港元“闪电收购”,合联缓解“产能饥渴”东曜“成功上岸”Guide View1月14日,药明合联宣布以每股4港元现金发起自愿要约,拟收购东曜药业,假设要约获全面接纳,最高总代价约为31.047亿港元,若药明合联最后获得东曜药业60%的股权,代价预计为18.55亿港元。收购完成后...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.